Acurion develops AI-driven diagnostic solutions that extract actionable genomic biomarker insights from standard pathology images.
Acurion has raised $4.3M in total funding. The most recent round was Seed. The last funding was announced in April 2026.
Acurion's investors include Mesa Verde Venture Partners, TK & Partners, Bootstrap Venture Partners, National Foundation for Cancer Research, Asian Fund For Cancer Research.
Acurion is headquartered in San Diego, United States.
Acurion develops AI-driven diagnostic solutions that extract actionable genomic biomarker insights from standard pathology images.
Acurion is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Acurion — Funding & Investors." VCBacked, April 2, 2026, https://www.vcbacked.co/company/acurion. Accessed July 31, 2026.
VCBacked. (2026). Acurion — Funding & Investors. Retrieved July 31, 2026, from https://www.vcbacked.co/company/acurion
{{cite web |title=Acurion — Funding & Investors |url=https://www.vcbacked.co/company/acurion |website=VCBacked |access-date=July 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated